BSE: AUROPHARMA - Aurobindo Pharma Limited

Rentabilität für sechs Monate: -31.44%
Dividendenrendite: +0.73%

Aktionsplan Aurobindo Pharma Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen Aurobindo Pharma Limited

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

weitere details
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

ISIN INE406A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.7306
Дивиденд ао 4.5
Сайт https://www.aurobindo.com
Цена ао 1081.4
Preisänderung pro Tag: -0.1433% (1081.4)
Preisänderung pro Woche: -3.66% (1120.85)
Preisänderung pro Monat: -5.09% (1137.75)
Preisänderung über 3 Monate: -12.72% (1237.2)
Preisänderung über sechs Monate: -31.44% (1574.95)
Preisänderung pro Jahr: +5.03% (1028.15)
Preisänderung über 3 Jahre: +69.22% (638.15)
Preisänderung über 5 Jahre: +126.79% (476.15)
Preisänderung über 10 Jahre: 0% (1079.85)
Preisänderung seit Jahresbeginn: -11.01% (1213.45)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 2.08 7
P/BV 2 7
P/E 18.84 7
EV/EBITDA 7.61 9
Gesamt: 6.88

Effizienz

Name Bedeutung Grad
ROA, % 7.47 2
ROE, % 11.2 4
Gesamt: 3.17

Dividenden

Name Bedeutung Grad
Div yield, % 0.7306 1.83
DSI 0.8571 8.57
Gesamt: 1.99

Pflicht

Name Bedeutung Grad
Debt/EBITDA 1.58 7
Gesamt: 8.4

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 26.24 4
Rentabilität Ebitda, % 2.24 1
Rentabilität EPS, % 12.08 2
Gesamt: 1.8
Weitere Details

ETF Aktie, % Rentabilität für das Jahr, % Dividenden, %
Fidelity Emerging Markets Multifactor ETF 1.65455 9.3 4.83083
VictoryShares Emerging Markets Value Momentum ETF 0.94165 13.66 4.52229
Invesco S&P Emerging Markets Momentum ETF 0.56274 18.98 2.50979
Hartford Multifactor Emerging Markets ETF 0.53562 11.21 5.04734
WisdomTree Emerging Markets Multifactor Fund 0.50144 16.97 3.61297
WisdomTree India Earnings Fund 0.33497 5.23 1.65591
iShares MSCI India ETF 0.29108 3.5 1.24292
Dimensional Emerging Markets Value ETF 0.28877 17.07 4.19508
Franklin FTSE India ETF 0.25957 20.52 1.25133
Avantis Emerging Markets Value ETF 0.23119 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.19961 17.6 3.1719
KraneShares MSCI Emerging Markets ex China Index ETF 0.19853 11.18 3.46245
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.19628 14.02 2.84808
JPMorgan Diversified Return Emerging Markets Equity ETF 0.12768 7.2 5.1761
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.12742 9.13 3.47133
iShares MSCI BIC ETF 0.12324 14.55 2.77084
SPDR Portfolio Emerging Markets ETF 0.10941 11.59 3.1879
iShares MSCI Emerging Markets Min Vol Factor ETF 0.10671 6.61 2.95411
Avantis Emerging Markets Equity ETF 0.08535 8.77 3.60513
WisdomTree Emerging Markets Efficient Core Fund 0.07784 17.03 3.08497
iShares MSCI Emerging Markets Asia ETF 0.0759 13.87 2.40119
Dimensional Emerging Markets Core Equity 2 ETF 0.06949 15.96 3.34087
John Hancock Multifactor Emerging Markets ETF 0.0674 4.68 3.42078
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.0633 2.43 4.35382
Franklin FTSE Asia ex Japan ETF 0.0631 14.43 2.66768
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.05497 15.84 3.04307
SPDR MSCI Emerging Markets StrategicFactors ETF 0.0478 8.65 3.55491
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.04449 12.46 3.59676
Dimensional World ex U.S. Core Equity 2 ETF 0.03598 13.06 3.62488
SPDR MSCI ACWI ex-US ETF 0.0325 7.85 3.3217
Vanguard ESG International Stock ETF 0.02 6.39 3.07501
iShares Core MSCI Total International Stock ETF 0.01792 6.4 3.25258
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01686 18.18 3.26685
iShares MSCI ACWI ETF 0.00474 -19.68 2.10908

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Mettu Madan Mohan Reddy Whole-Time Director 52.35M 1960 (65 Jahre)
Mr. Santhanam Subramanian Chief Financial Officer 21.06M 1961 (64 Jahr)
Mr. Sanjeev Indravadan Dani COO & Head of Formulations N/A 1960 (65 Jahre)
Dr. S. Vijaya Kumar President of Technical N/A 1966 (59 Jahre)
Mr. Arvind Bothra Head of Investor Relations & Corporate Communications N/A
Mr. B. Adi Reddy Compliance Officer & Company Secretary 4.76M
Mr. G. P. Prasad Senior Vice President of Global Finance & Operations N/A
Dr. Sudhir Bimal Singhi Head of Global Finance Operations N/A 1969 (56 Jahre)
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958 (67 Jahre)
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. President of Biologics, CEO of Biologics, Vaccines and Peptid & Director 1981 (44 Jahr)

Adresse: India, Hyderabad, Galaxy Plot No. 1 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.aurobindo.com